ACTIVE INGREDIENT
ACTIVE INGREDIENTS: NIACINAMIDE (2.00%)
ACTIVE INGREDIENTS: NIACINAMIDE (2.00%)
Inactive ingredients: SACCHAROMYCES FERMENT,GLYCERIN,CYCLOPENTASILOXANE,TRIETHYLHEXANOIN,CETEARYL ALCOHOL,1,2-HEXANEDIOL,ISOSTEARYL ISOSTEARATE,PIPER METHYSTICUM LEAF/ROOT/STEM EXTRACT,ALOE BARBADENSIS LEAF EXTRACT,ARCTIUM LAPPA ROOT EXTRACT,DIMETHICONE,PHELLINUS LINTEUS EXTRACT,LECITHIN,HYDROGENATED LECITHIN,SOLUBLE COLLAGEN,BATYL ALCOHOL,CAPRYLIC/CAPRIC TRIGLYCERIDE,STEARIC ACID,PORTULACA OLERACEA EXTRACT,PUERARIA THUNBERGIANA ROOT EXTRACT,CNIDIUM OFFICINALE ROOT EXTRACT,GLYCYRRHIZA GLABRA (LICORICE) ROOT EXTRACT,PAEONIA LACTIFLORA ROOT EXTRACT,GLYCERYL CAPRYLATE,HYDROXYPROPYL METHYLCELLULOSE STEAROXY ETHER,WATER,CITRUS AURANTIUM DULCIS (ORANGE) FRUIT WATER,TOCOPHERYL ACETATE,HIBISCUS ESCULENTUS FRUIT EXTRACT,LINUM USITATISSIMUM (LINSEED) SEED EXTRACT,ALTHAEA OFFICINALIS LEAF/ROOT EXTRACT,ANTHEMIS NOBILIS FLOWER EXTRACT,FOENICULUM VULGARE (FENNEL) LEAF EXTRACT,HOUTTUYNIA CORDATA EXTRACT,OCIMUM BASILICUM (BASIL) FLOWER/LEAF EXTRACT,CENTELLA ASIATICA EXTRACT,CALENDULA OFFICINALIS FLOWER EXTRACT,ALOE BARBADENSIS LEAF JUICE,CITRUS GRANDIS (GRAPEFRUIT) PEEL OIL,OLEA EUROPAEA (OLIVE) FRUIT OIL,SQUALANE,BISABOLOL,DISODIUM EDTA,ETHYLHEXYLGLYCERIN,CITRUS AURANTIFOLIA (LIME) OIL,GLYCERYL STEARATE,PEG-100 STEARATE,SORBITAN STEARATE,SUCROSE STEARATE,BUTYLENE GLYCOL,RIBES NIGRUM (BLACK CURRANT) SEED OIL,ARGANIA SPINOSA KERNEL OIL,SODIUM METHYL STEAROYL TAURATE,SODIUM HYALURONATE,XANTHAN GUM,ROSE FLOWER OIL,CERAMIDE 3,DICAPRYLYL CARBONATE,ILLICIUM VERUM (ANISE) FRUIT/SEED OIL,SUCROSE DISTEARATE,FOLIC ACID,CHOLESTEROL,RAFFINOSE,HYDROGENATED POLYDECENE,PHOSPHOLIPIDS,PHYTOSPHINGOSINE,TROMETHAMINE,CERAMIDE 2,PANTHENOL,PALMITOYL PENTAPEPTIDE-4
PURPOSE: [BRIGHTENING] This facial cream brightens skin complexion and makes the skin clear and transparent
CAUTIONS: 1. For external use only 2. Avoid contact with eyes and mouth 3. Discontinue us if signs of irritation or rashes appear 4. Keep out of reach of children 5. Replace the cap after use
KEEP OUT OF REACH OF CHILDREN
HOW TO USE: Apply an appropriate amount to the entire face and gently pat for absorption.
HOW TO USE: Apply an appropriate amount to the entire face and gently pat for absorption.
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 8806173416677 | GTIN-13: 8806173416677 EAN-13: 8806173416677 GTIN storage (14 digits): 08806173416677 | saccharomyces the first cream carton.jpg |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| NIACINAMIDE | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| NIACINAMIDE | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| TRIETHYLHEXANOIN | INACTIVE INGREDIENT | 7K3W1BIU6K | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51346-334 | 51346-334-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
| TRIETHYLHEXANOIN | 7K3W1BIU6K | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAMUSCULAR | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / IONTOPHORESIS | 168.1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ecff35f3-7f26-4fb0-8428-95473f92f010 | d5fde241-2ae1-4e78-910e-7cd715053e24 | 2021-07-05 | Warnings | d5fde241-2ae1-4e78-910e-7cd715053e24 |
Adverse event summaries are temporarily unavailable. Other product information remains available.